Owner Pharmasset Inc.

Inventors Chun, Byoung-Known; Stuyver, Lieven J.; Watanabe, Kyoichi A.; Wang, Peiyuan; Hollecker, Laurent; Hassan, Abdalla

Agent Davies Collison Cave

Pub. Number AU-B-2003257157

PCT Number PCT/US03/24324

PCT Pub. Number WO2004/013300

Priority 60/453,716 01.08.02 US

Filing date 1 August 2003

Wipo publication date 23 February 2004

Acceptance publication date 8 October 2009

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 31/7056 (2006.01)

A61K 31/7068 (2006.01)

A61K 31/7072 (2006.01)

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 487/16 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms